Glucocorticoids Suppress Corticotropin-Releasing Hormone and Vasopressin Expression in Human Hypothalamic Neurons1
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are widely used in clinical practice in a variety of immune-mediated and neoplastic diseases, mostly for their immunosuppressive, leukopenic, antiedematous, or malignancy-suppressive actions. However, their usage is limited because of serious and sometimes life-threatening side-effects. Endogenous glucocorticoids are secreted by the adrenal cortex under the control of the hypothalamus and the pituitary gland. This hypothalamo-pituitary-adrenal axis, in turn, is under the negative feedback control of glucocorticoids. Although the suppression of adrenocortical and pituitary gland functions by glucocorticoids has been shown in humans, a feedback effect at the level of the hypothalamus, as shown in rat, has not been reported to date. The present study shows for the first time that glucocorticoids suppress both CRH and vasopressin (AVP) in the human hypothalamus. We studied immunocytochemically the postmortem hypothalami of nine corticosteroid-exposed subjects and eight controls. The number of CRH-expressing cells in the hypothalamic paraventricular nucleus of glucocorticoid-exposed patients was only 3.3% of that in the controls, and the total immunoreactivities for AVP were 31% and 33% of that in the controls in the supraoptic nucleus and the paraventricular nucleus, respectively, whereas the immunoreactivity for oxytocin did not differ between the two groups. Suppression of hypothalamic CRH and AVP neurons by glucocorticoids may have important consequences for neuroendocrinological mechanisms such as the disturbance of water balance during the treatment as well as the immunological processes in the brain and the pathogenesis of the withdrawal syndrome after discontinuation of corticosteroid treatment. In addition, as both AVP and CRH neurons also project to other brain structures and influence memory, mood, and behavior, their suppression by glucocorticoids may be responsible for at least part of the central nervous system side-effects of glucocorticoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
MacPhee, I. A., Antoni, F. A., & Mason, D. W. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.2.431 · Cited by 328
DeBold, C. R., Sheldon, W. R., DeCherney, G. S., Jackson, R. V., Alexander, A. N., Vale, W., Rivier, J., & Orth, D. N. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111240 · Cited by 189
Herman, J. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903630103 · Cited by 129
Fink, G., Robinson, I. C., & Tannahill, L. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017165 · Cited by 121 · cited 2×
“dance with the animal experimental literature (26, 27).”
Background
Cited by
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Salivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
The stress system in the human brain in depression and neurodegeneration
Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984
“Cortisol, and synthetic corticosteroids inhibit the release of CRH, vasopressin (Erkut et al., 1998, 2002) and ACTH.”
BackgroundThe stress system in depression and neurodegeneration: Focus on the human hypothalamus
Bao, A.-M., Meynen, G., & Swaab, D. F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 548
Self-citationThe selfish brain: Competition for energy resources
Peters, A., Schweiger, U., Pellerin, L., Hubold, C., Oltmanns, K. M., Conrad, M., Schultes, B., Born, J., & Fehm, H. L. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.002 · Cited by 489
Lucassen, P. J., Pruessner, J., Sousa, N., Almeida, O. F. X., Van Dam, A. M., Rajkowska, G., Swaab, D. F., & Czéh, B. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1223-5 · Cited by 441
Self-citationSánchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04657.2000 · Cited by 420
Lucassen, P. J., Müller, M. B., Holsboer, F., Bauer, J., Holtrop, A., Wouda, J., Hoogendijk, W. J. G., De Kloet, E. R., & Swaab, D. F. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63988-0 · Cited by 286
Self-citationThe human hypothalamus in mood disorders: The HPA axis in the center
Bao, A.-M., & Swaab, D. F. (2019) · IBRO Reports · doi:10.1016/j.ibror.2018.11.008 · Cited by 212
“the atypical depression, which shows high levels of corticosteroids, accompanied by low levels of CRH (Gold et al., 2002; Erkut et al., 1998).”
BackgroundEndocrine withdrawal syndromes
Hochberg, Z., Pacak, K., & Chrousos, G. P. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0014 · Cited by 181
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Glucocorticoid receptor protein expression in human hippocampus; stability with age
Wang, Q., Van Heerikhuize, J., Aronica, E., Kawata, M., Seress, L., Joels, M., Swaab, D. F., & Lucassen, P. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.019 · Cited by 144
“…against the extreme C-terminal part (amino acids 38e39) of corticotropin-releasing factor (CRF), has been characterized extensively before (de Goeij et al., 1992; van Oers et al., 1989) and has been used before on human hypothalamic sections as well (Erkut et al., 1998; Raadsheer et al., 1993).”
BackgroundMeynen, G., Unmehopa, U. A., van Heerikhuize, J. J., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.010 · Cited by 108
“…receptors are present in both the PVN and SON in rats (Morimoto et al., 1996) as well as in rhesus monkeys (Sanchez et al., 2000), and in our group Erkut et al. found that in humans not only AVP in the PVN but also in the SON responds to glucocorticoid plasma levels (Erkut et al., 1998).”
BackgroundPak, T. R., Chung, W. C. J., Hinds, L. R., & Handa, R. J. (2007) · Endocrinology · doi:10.1210/en.2007-0086 · Cited by 69
Cuesta, M., Garrahy, A., Slattery, D., Gupta, S., Hannon, A. M., Forde, H., McGurren, K., Sherlock, M., Tormey, W., & Thompson, C. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13128 · Cited by 65
Pak, T. R., Chung, W. C. J., Hinds, L. R., & Handa, R. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2009 · Cited by 25
Metadata
- Authors
- Erkut, Z. A., Pool, C., & Swaab, D. F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-06
- Volume
- 83
- Issue
- 6
- Pages
- 2066-2073
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2114882341
- Cited by
- 135
- References
- 7
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.